Vaccine 2014-05-01

A broadly-protective vaccine against meningococcal disease in sub-Saharan Africa based on generalized modules for membrane antigens (GMMA).

Oliver Koeberling, Emma Ispasanie, Julia Hauser, Omar Rossi, Gerd Pluschke, DominiqueA Caugant, Allan Saul, CalmanA MacLennan

Index: Vaccine 32(23) , 2688-95, (2014)

Full Text: HTML

Abstract

Neisseria meningitidis causes epidemics of meningitis in sub-Saharan Africa. These have mainly been caused by capsular group A strains, but W and X strains are increasingly contributing to the burden of disease. Therefore, an affordable vaccine that provides broad protection against meningococcal disease in sub-Saharan Africa is required.

Related Compounds

  • 4-Nitrophenyl phos...
  • Cytidine 5'-monoph...
  • Ethylenediaminetet...

Related Articles:

Flow perfusion co-culture of human mesenchymal stem cells and endothelial cells on biodegradable polymer scaffolds.

2014-07-01

[Ann. Biomed. Eng. 42(7) , 1381-90, (2014)]

Development of chimeric candidate vaccine against HPV18: a proof of concept.

2015-06-01

[Immunol. Res. 62 , 189-97, (2015)]

Effect of nanovaccine chemistry on humoral immune response kinetics and maturation.

2014-11-21

[Nanoscale 6(22) , 13770-8, (2014)]

Glioma cells with the IDH1 mutation modulate metabolic fractional flux through pyruvate carboxylase.

2014-01-01

[PLoS ONE 9(9) , e108289, (2014)]

Piperine inhibits the growth and motility of triple-negative breast cancer cells.

2015-02-01

[Cancer Lett. 357(1) , 129-40, (2014)]

More Articles...